Related Experiment Video
Updated: Sep 19, 2025

10:51
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
Published on: April 23, 2021
4.3K
Comparing Canada's OncoSim-Breast model with the United States' Cancer Intervention and Surveillance Modeling Network
Oguzhan Alagoz1, Claude Nadeau2, Jean Hai Ein Yong3
1Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Health Reports
|June 18, 2025
Summary
Comparing breast cancer models, starting mammography screening at age 40 for women averts more deaths and gains more life years than starting at age 50. OncoSim-Breast aligns with US CISNET models.
Area of Science:
- Oncology
- Public Health
- Health Economics
Background:
- The OncoSim-Breast model simulates breast cancer events in Canada.
- This study compares OncoSim-Breast with US Cancer Intervention and Surveillance Modeling Network (CISNET) models.
- The comparison focuses on extending mammography screening to women aged 40-49.
Purpose of the Study:
- To compare the OncoSim-Breast model's projections with CISNET models.
- To evaluate the impact of initiating breast cancer screening at age 40 versus age 50.
Main Methods:
- Used Canadian and US demographic data, competing mortality, and test performance.
- Analyzed 10 digital mammography screening scenarios with perfect adherence.
- Calculated lifetime outcomes for a cohort of 40-year-old women born in 1980.
Main Results:
- OncoSim-Breast projected 1.7 breast cancer deaths averted and 53 life years gained per 1,000 women by starting screening at age 40 (vs. 50).
- CISNET models projected a median of 1.3 deaths averted (range 0.8-3.2) and 43 life years gained (range 31-103).
- Secondary outcomes showed consistency between OncoSim-Breast and CISNET models.
Conclusions:
- OncoSim-Breast's estimates for earlier breast cancer screening align with CISNET model results.
- The findings support the impact of extending mammography screening to younger women.
Related Concept Videos
Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458

